Insulin management
First Claim
1. A system comprising:
- a glucometer measuring blood glucose measurements separated by a time interval; and
a dosing controller in communication with the glucometer, the dosing controller including a data processing device and non-transitory memory in communication with the data processing device, the dosing controller;
receiving blood glucose measurements of a patient from the glucometer;
receiving patient information; and
selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, the selected subcutaneous insulin treatment includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients, wherein during the standard subcutaneous program, the dosing controller;
determines a blood glucose type of the received blood glucose measurement;
determines a correction insulin dose based on the blood glucose type by calculating;
CBx=(BGx−
BGTarget)/CF;
wherein CBx is the correction dose based on blood glucose type X, BGx is the blood glucose measurement, BGTarget is a target blood glucose value of a patient, and CF is a correction factor; and
when the determined blood glucose type is one of a pre-breakfast blood glucose measurement, a pre-lunch blood glucose measurement, or a pre-dinner blood glucose measurement;
determines if a subsequent blood glucose measurement associated with a subsequent blood glucose type has been received from the glucometer;
when the subsequent blood glucose measurement associated with the subsequent blood glucose type has been received, determines an adjustment factor for adjusting a next day'"'"'s recommended meal bolus for the determined blood glucose type governed by the blood glucose measurement for the subsequent blood glucose type; and
determines the next day'"'"'s recommended meal bolus at the time of day associated with the determined blood glucose type by multiplying a current day'"'"'s recommended meal bolus associated with the determined blood glucose type times the adjustment factor; and
transmits the correction insulin dose to an administration device in communication with the dosing controller, the administration device comprising;
a doser; and
an administration computing device in communication with the doser, the administration computing device configured to cause the doser to administer a number of units of insulin to the patient using the correction insulin dose.
4 Assignments
0 Petitions
Accused Products
Abstract
A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. The blood glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.
272 Citations
14 Claims
-
1. A system comprising:
-
a glucometer measuring blood glucose measurements separated by a time interval; and a dosing controller in communication with the glucometer, the dosing controller including a data processing device and non-transitory memory in communication with the data processing device, the dosing controller; receiving blood glucose measurements of a patient from the glucometer; receiving patient information; and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, the selected subcutaneous insulin treatment includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients, wherein during the standard subcutaneous program, the dosing controller; determines a blood glucose type of the received blood glucose measurement; determines a correction insulin dose based on the blood glucose type by calculating;
CBx=(BGx−
BGTarget)/CF;wherein CBx is the correction dose based on blood glucose type X, BGx is the blood glucose measurement, BGTarget is a target blood glucose value of a patient, and CF is a correction factor; and when the determined blood glucose type is one of a pre-breakfast blood glucose measurement, a pre-lunch blood glucose measurement, or a pre-dinner blood glucose measurement; determines if a subsequent blood glucose measurement associated with a subsequent blood glucose type has been received from the glucometer; when the subsequent blood glucose measurement associated with the subsequent blood glucose type has been received, determines an adjustment factor for adjusting a next day'"'"'s recommended meal bolus for the determined blood glucose type governed by the blood glucose measurement for the subsequent blood glucose type; and determines the next day'"'"'s recommended meal bolus at the time of day associated with the determined blood glucose type by multiplying a current day'"'"'s recommended meal bolus associated with the determined blood glucose type times the adjustment factor; and transmits the correction insulin dose to an administration device in communication with the dosing controller, the administration device comprising; a doser; and an administration computing device in communication with the doser, the administration computing device configured to cause the doser to administer a number of units of insulin to the patient using the correction insulin dose. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
Specification